[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:acute-bilineal-leukemia":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":22,"states":23},"Acute Bilineal Leukemia",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05848687","TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II",[11],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:16:24.970704Z","2026-05-05T02:43:29.336397Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT03683433","Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation",[19],"Phase 2","2026-08-26T02:15:43.339060Z","2026-04-29T02:57:57.075222Z",[],[]]